University Hospital Zurich
Zurich, 8091, Switzerland
NCT Number: NCT03774030
A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and assess strengths and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomised active comparator clinical evaluation which will be conducted mono centric at the University Hospital of Zürich.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Zurich, 8091, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The focus is a comparison of 3 hearing aid algorithms in a virtual 3-D complex audio Environment.
Time frame: 6 weeks
The participant starts the acoustic stimulus, tries to identify the direction of the stimulus as precise as possible and validates the final position. This is interpreted as reaction time with regard to spatial quality in seconds [s].
Sonova AG
Industry
Acronym: HEAR3D_CE2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04180254
Ability, Spatial, Behavior
Zurich, Switzerland
View Trial DetailsNCT03514758
Ability, Spatial, Behavior
Zurich, Switzerland
View Trial DetailsNCT03781583
Behavior, Eye Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT05768620
Behavior, Cognition Disorders
Milan, Lombardy, Italy
View Trial Details